KalVista Pharmaceuticals Inc
(NASDAQ:KALV)
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
top performing KALV trades
Recent Trades
Largest Trades
Top Performing
Largest Traders
Most Active Traders
Recent Trades
View the most recent KalVista Pharma trades made by congress members.
![]() Chris JacobsHouse (R-NY) | $1K - $15K | stock | Purchase | Jan 20, 2023 | Dec 12, 2022 | House |